Featured Article
Precision Oncology Today
Magazine
The Evolution of CRISPR Technology from Editing to Diagnostics
The discovery of these new Cas enzymes really catalyzed researchers to investigate how CRISPR technology could be used in diagnostics and over the last few years several biotech companies have been set up to explore this potential.
The Pandemic Supercharged Decentralized Trials, Now What?
For anyone in the clinical trial field, no matter how peripherally, the onset of the COVID-19 pandemic was dramatic. Teams were mobilized for a full-throttle shift to decentralized clinical trials (DCTs).
Trending on Inside Precision Medicine
Small Molecule Developed Potentially Making Immunotherapy Available to All Cancer Patients
Research led by Tel Aviv University and the University of Lisbon has identified a small molecule inhibitor which may be a more accessible and effective alternative to anti-PD-1/PD-L1 immunotherapy antibodies already being used to treat a range of cancers.
Protein That Causes Preterm Labor Uncovered
The protein Piezo1 is responsible for regulating the mechanics of the uterus and linked to preterm labor.
BD, Labcorp to Collaborate on Flow Cytometry-Based CDx Offerings
The collaboration will create a framework to allow a joint offering to develop, manufacture, market and commercialize flow cytometry-based companion diagnostics (CDx) for cancer and other diseases.
